Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00258778 | Phase I Single Dose-Escalation Safety Study of Human Glucocerebrosidase (prGCD) | PHASE1 | COMPLETED | 6 | — | — | Nov 1, 2005 | Jan 1, 2006 | Dec 4, 2006 | - | — |
| Name | Type | Description |
|---|---|---|
| Human Glucocerebrosidase (prGCD) | DRUG | - |